⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17930961 | 0.81 | — | — | |
| SCHEMBL19408158 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL2492160 | 0.72 | MAP2K7 (0.30) | — | |
| SCHEMBL789393 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL25436300 | 0.69 | ROCK2 (0.30) | — | |
| SCHEMBL9517341 | 0.69 | PIK3CD (0.31) | — | |
| SCHEMBL8991362 | 0.69 | ROCK2 (0.30) | — | |
| SCHEMBL16681835 | 0.69 | MEN1 (0.32) | — | |
| Fluoride SCHEMBL2295019 | 0.69 | ROCK2 (0.30) | — | |
| Fluoride SCHEMBL2295012 | 0.69 | ROCK2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107148423-A | Thionucleoside derivatives or its salt and medical composition | 富士胶片株式会社 | 2017-09-08 | — | — | CN | disclosed |
| US-20120264679-A1 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | SCYNEXIS, INC. (US) | 2012-10-18 | — | — | US | disclosed |
| EP-1802650-B1 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | SCYNEXIS INC (US) | 2011-10-26 | — | — | EP | disclosed |
| US-20100167996-A1 | 3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection | FLIRI HANS GEORG | 2010-07-01 | — | — | US | disclosed |
| US-7718767-B2 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | SCYNEXIS, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| EP-1802650-A4 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | SCYNEXIS INC (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1802650-A2 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | Scynexis, Inc. (US) | 2007-07-04 | — | — | EP | disclosed |
| US-7196161-B2 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | SCYNEXIS INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-20060160727-A1 | 3-Ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | FLIRI HANS G | 2006-07-20 | — | — | US | disclosed |
| US-20060089301-A1 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | SCYNEXIS, INC. | 2006-04-27 | — | — | US | disclosed |
| WO-2006039668-A2 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | SCYNEXIS, INC (US) | 2006-04-13 | — | — | WO | disclosed |